Exploratory Evaluation of Bezlotoxumab on Outcomes Associated With Clostridioides difficile Infection in MODIFY I/II Participants With Cancer

BACKGROUND: The incidence of Clostridioides difficile infection (CDI) is reportedly higher and the cure rate lower in individuals with cancer vs those without cancer. An exploratory post hoc analysis of the MODIFY I/II trials (NCT01241552/NCT01513239) investigated how bezlotoxumab affected the rate...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Open Forum Infect Dis
Egile Nagusiak: Cornely, Oliver A, Mullane, Kathleen M, Birch, Thomas, Hazan-Steinberg, Sabine, Nathan, Richard, Bouza, Emilio, Calfee, David P, Ellison, Misoo Chung, Wong, Michael T, Dorr, Mary Beth
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2020
Gaiak:
Major Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7029680/
https://ncbi.nlm.nih.gov/pubmed/32099847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa038
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak